Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03109106 · ClinicalTrials.gov registry record · NA

Procalcitonin for Stewardship in Respiratory Infections A Stewardship Project

A NA study, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
189
Enrollment target

NCT03109106: Completed NA study, sponsored by Johns Hopkins University.

NCT03109106 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 189 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03109106, a NA study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
189 participants
Enrollment target

Study Summary

Antibiotics are overused in hospitals nationwide, leading to unnecessary drug costs and adverse events. Antibiotic stewardship is now a national and international priority and regulatory authorities are mandating antibiotic stewardship programs in all hospitals. Respiratory infections account for a large percentage of antibiotic overuse. Procalcitonin has been shown to help providers significantly shorten the duration of antibiotic therapy in respiratory infections. As such, this institution seeks to evaluate the impact of PCT-guided antibiotic management on antibiotic use in subjects with acute Lower Respiratory Tract Infection (LRTI) with or without sepsis. Multiple studies have been conducted in Europe and demonstrate the safety of the PCT-guided antibiotic management in pneumonia as well as sepsis. This study will apply PCT-guided therapy to those populations in an all-US study evaluating patient outcomes along with safety and efficacy.

Interventions

  • DEVICE PCT Arm

Trial Details

FieldValue
Enrollment Target 189 participants
Start Date 2017-04-15
Est. Completion 2018-03-15
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT03109106

The ClinicalTrials.gov registry entry for NCT03109106 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 189 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which PCT Arm is the first listed.

NCT03109106 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03109106 about?

NCT03109106 is a clinical study titled "Procalcitonin for Stewardship in Respiratory Infections A Stewardship Project". Antibiotics are overused in hospitals nationwide, leading to unnecessary drug costs and adverse events. Antibiotic stewardship is now a national and international priority and regulatory authorities are mandating antibiotic stewardship programs in all hospitals. Respiratory infections account for a ...

What is the current status of trial NCT03109106?

This trial is currently completed. It is a NA study. The enrollment target is 189 participants. The study started on 2017-04-15. Estimated completion is 2018-03-15.

What interventions are being tested in trial NCT03109106?

The interventions under investigation include: PCT Arm (DEVICE).

Who is sponsoring clinical trial NCT03109106?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.